58
Views
4
CrossRef citations to date
0
Altmetric
Original Research

Is monthly retreatment with intravitreal bevacizumab (Avastin®) necessary in neovascular age-related macular degeneration?

, , , &
Pages 307-314 | Published online: 08 Apr 2010

Keep up to date with the latest research on this topic with citation updates for this article.

Articles from other publishers (4)